115 Followers on Owler

Idorsia

is a Switzerland-based biopharmaceutical company that discovers and develops small molecule therapeutics for the treatment of CNS and cardiovascular disorders... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights

Idorsia

is a Switzerland-based biopharmaceutical company that discovers and develops small molecule therapeutics for the treatment of CNS and cardiovascular disorders... Read more
Idorsia Interim-CEO: Jean-Paul Clozel

Interim-CEO

Jean-Paul Clozel

CEO Approval Rating

- -/100

2017

PublicSIX Swiss ExchangeIDIA

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
28342836 NAICS listing

Annual Revenue
$252.5M
Employees
689
Funding
$505.4M
Investments
1

News

Funding
Aug 30, 2025
FinanzNachrichten
Idorsia received $253.5M in Post-IPO Debt Funding
Leadership Change
Jul 01, 2025
FinanzNachrichten
Srishti Gupta joined Idorsia as CEO

Idorsia Competitors

1Rhizen
2Clinuvel
3Noema Pharma
4Novartis
5Vifor (International)
6Roche
7Biogen
8Genentech
9Galapagos
10Amgen
Unlock 19 + competitors

Trending Companies